AI assistant
Emergent BioSolutions Inc. — Director's Dealing 2016
Jan 6, 2016
32870_dirs_2016-01-06_01e048e4-1aa2-4dae-ae3e-47491015bb94.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2016-01-04
Reporting Person: Bailey Sue (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-01-04 | Common Stock | M | 5760 | $11.67 | Acquired | 34260 | Direct |
| 2016-01-04 | Common Stock | S | 5760 | $38.97 | Disposed | 28500 | Direct |
| 2016-01-04 | Common Stock | M | 2880 | $16.13 | Acquired | 31380 | Direct |
| 2016-01-04 | Common Stock | S | 2880 | $38.77 | Disposed | 28500 | Direct |
| 2016-01-04 | Common Stock | M | 2880 | $22.02 | Acquired | 31380 | Direct |
| 2016-01-04 | Common Stock | S | 2880 | $38.46 | Disposed | 28500 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-01-04 | Stock Option | $11.67 | M | 5760 | Disposed | 2019-05-20 | Common Stock (5760) | Direct |
| 2016-01-04 | Stock Option | $16.13 | M | 2880 | Disposed | 2020-05-19 | Common Stock (2880) | Direct |
| 2016-01-04 | Stock Option | $22.02 | M | 2880 | Disposed | 2021-05-18 | Common Stock (2880) | Direct |
Footnotes
F1: Consists of an option granted under the company's stock incentive plan on May 21, 2009.
F2: Consists of an option granted under the company's stock incentive plan on May 20, 2010.
F3: Consists of an option granted under the company's stock incentive plan on May 19, 2011.
F4: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Bailey.
F5: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.58 to $39.16, inclusive.
F6: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.31 to $39.11, inclusive.
F7: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.27 to $38.68, inclusive.
F8: The option vested in three equal installments in May 2010, 2011 and 2012.
F9: The option vested in three equal installments in May 2011, 2012 and 2013.
F10: The option vested in three equal installments in May 2012, 2013 and 2014.